Browse All

Current Filters

CLEAR FILTER x

TITLE

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment

Author:Alford, Susan   Johannsen, Peter   Bentsen, Marie   Belmont-Rausch, Dylan   Carstensen, Lisbeth   Jeppesen, Rose   Martino, Gabriel   Jimenez Mausbach, Marti   Knudsen, Lotte   

Session Name:P3: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P3.012  

Author Institution:Novo Nordisk, Inc., Plainsboro, NJ  Novo Nordisk, Copenhagen, Denmark  

Early Alzheimer’s Disease Diagnosis and Blood Biomarkers: Primary Care Physician Attitudes, Perceptions, and Barriers in the USA

Author:Alford, Susan   Aurora, Sheena K.   Coppinger, Justine   Jimenez-Mausbach, Marti   Laird, Rosemary D.   Pandey, Hemant   Ray, Sutapa   Burns, Jeffrey M.   

Session Name:P4: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease and Diagnostics 1  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P4.009  

Author Institution:Novo Nordisk, Inc., Plainsboro, NJ  C2N Diagnostics LLC, Saint Louis, MO  Novo Nordisk A/S, Copenhagen, Denmark  NAN Navigator Inc., Orlando, FL  Brain and Spine Center, Chandler, AZ  University of Kansas Alzheimer's Disease Research Center, Kansas City, KS